Variant report
Variant | esv1839868 |
---|---|
Chromosome Location | chr1:104659907-104672830 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:4)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr1:104659954..104662571-chr1:104673545..104675551,2 | K562 | blood: |
(count:4 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-AMY1C-2 | chr1:104672443-104672483 | NONHSAT004905 |
2 | lnc-AMY1C-2 | chr1:104672444-104672483 | XLOC_000326 |
3 | lnc-AMY1C-2 | chr1:104668178-104668541 | NONHSAT004905 |
4 | lnc-AMY1C-2 | chr1:104668179-104668541 | XLOC_000326 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537908482 | chr1:104661400-104661401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115348283 | chr1:104661403-104661404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs72689166 | chr1:104661417-104661418 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs542552193 | chr1:104661418-104661419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372939904 | chr1:104661432-104661433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs572698385 | chr1:104661436-104661437 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145310204 | chr1:104661477-104661478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs543478089 | chr1:104661487-104661488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs114600053 | chr1:104661509-104661510 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs531710275 | chr1:104661520-104661521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs185057275 | chr1:104661521-104661522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs72989529 | chr1:104661522-104661523 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs113911594 | chr1:104661594-104661595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs547765423 | chr1:104661610-104661611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373319455 | chr1:104661620-104661621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72689167 | chr1:104661621-104661622 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs534079289 | chr1:104661642-104661643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs552103814 | chr1:104661682-104661683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs116437314 | chr1:104663830-104663831 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs377471658 | chr1:104663831-104663832 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539465634 | chr1:104663839-104663840 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370311319 | chr1:104663893-104663894 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570047282 | chr1:104663894-104663895 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs146862120 | chr1:104663895-104663896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs72689174 | chr1:104663932-104663933 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs574130978 | chr1:104663951-104663952 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs534819057 | chr1:104663957-104663958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553474108 | chr1:104663959-104663960 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs191806790 | chr1:104664005-104664006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs35329105 | chr1:104664032-104664033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184151967 | chr1:104664088-104664089 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs563660039 | chr1:104664091-104664092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs576424357 | chr1:104664096-104664097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs72689176 | chr1:104664097-104664098 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs561871713 | chr1:104664106-104664107 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529125143 | chr1:104664109-104664110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs79583166 | chr1:104664120-104664121 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs72689177 | chr1:104664130-104664131 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs532869951 | chr1:104664151-104664152 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140652845 | chr1:104664153-104664154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569282975 | chr1:104664161-104664162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537352099 | chr1:104664202-104664203 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549226350 | chr1:104664252-104664253 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs72689179 | chr1:104664328-104664329 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs370035092 | chr1:104664336-104664337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs535270616 | chr1:104664355-104664356 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs112358031 | chr1:104664396-104664397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs374846615 | chr1:104664406-104664407 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs553270940 | chr1:104664409-104664410 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs578076478 | chr1:104664450-104664451 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Coronary Disease | 20032323 | CNVD |
Prostate cancer | 21965145 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Stargardt''s disease | 17277736 | CNVD |
Neuroblastoma | 17897457 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-syndromic sensorineural hearing loss | 22290220 | CNVD |
Liposarcoma | 21253554 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Cancer | 21499728 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
Neuroblastoma | 17535989 | CNVD |
Pheochromocytoma | 17535989 | CNVD |
Prostate cancer | 16705090 | CNVD |
Astrocytoma | 17934521 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 22495311 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Chordoma | 21602918 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Melanoma | 18172304 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 21129771 | CNVD |
Autosomal dominant nocturnal frontal lobe epilepsy | 18472482 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Thrombocytopenia-absent radius syndrome | 21933853 | CNVD |
Psychiatric disorder | 22848183 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 20409316 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17393978 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cervical cancer | 21062161 | CNVD |
Cancer | 21183584 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21364760 | CNVD |
Rett syndrome | 21593744 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Cancer | 22429812 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Autism | 17483303 | CNVD |
Intestinal disease | 21956041 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Schizophrenia | 17879154 | CNVD |
Mental retardation | 17124404 | CNVD |
Intestinal disease | 17828263 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Immune disease | 21076436 | CNVD |
Immune disease | 21042300 | CNVD |
Lung cancer | 17086460 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 17550852 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:104661400-104661800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
2 | chr1:104663800-104664200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr1:104663800-104664400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
4 | chr1:104664400-104668000 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
5 | chr1:104667400-104667800 | Enhancers | Fetal Heart | heart |
6 | chr1:104667800-104669000 | Enhancers | Primary hematopoietic stem cells | blood |
7 | chr1:104667800-104669000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
8 | chr1:104667800-104669200 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
9 | chr1:104668000-104668400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
10 | chr1:104668000-104668400 | Enhancers | Placenta Amnion | Placenta Amnion |
11 | chr1:104668000-104669400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
12 | chr1:104668200-104668800 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
13 | chr1:104668400-104674800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
14 | chr1:104668600-104669000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
15 | chr1:104669400-104678400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |